ERBB2 and neoplasm: The cohort diagnosed with HER2-negative EIBC who received adjuvant chemotherapy had a similar distribution across most characteristics with small differences in relation to age, stage grouping, invasive grade, tumour stage, nodal involvement and use of radiotherapy (online supplemental table A4).